The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients
Pierre Rosenbaum, Cécile Artaud, Sylvie Bay, Christelle Ganneau, Mario Campone, Suzette Delaloge, Carole Gourmelon, Delphine Loirat, Jacques Médioni, F Pein, Marie‐Paule Sablin, Olivier Trédan, Andréa Varga, Claude Leclerc
Topics & Concepts
EpitopeAntibodyCytotoxic T cellImmunologyAntigenCancerBiologyCancer researchMedicineIn vitroInternal medicineBiochemistryImmunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches